1,438
Views
2
CrossRef citations to date
0
Altmetric
Article

Early rheumatoid arthritis: focus on RA in the developing world

, &
Pages 164-166 | Received 24 Nov 2015, Accepted 28 Mar 2016, Published online: 05 May 2016

References

  • Modi GM, Cardiel MH. Challenges in the management of rheumatoid arthritis in developing countries. Best Pract Res Clin Rheumatol. 2008;22(4):621–41. doi:10.1016/j.berh.2008.04.003.
  • Chopra A, Abdel-Nasser A. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol. 2008;22(4):583–604. doi:10.1016/j.berh.2008.07.001.
  • Adebajo AO, Reid DM. The pattern of rheumatoid arthritis in West Africa and comparison with a cohort of British patients. Q J Med. 1991;80(292):633–40.
  • Tikly M, Zannettou N, Hopley M. A longitudinal study of rheumatoid arthritis in South Africans. MedGenMed. 2003;5(1):2.
  • Hodkinson B, Musenge E, Ally M, et al. Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis. Scand J Rheumatol. 2012;41(5):366–74. doi:10.3109/0.009742.2012.676065.
  • Okoye RC, Ollier W, Jaraquemada D, et al. HLA-D region heterogeneity in a Nigerian population. Tissue Antigens. 1989;33(4):445–56.
  • Pile KD, Tikly M, Bell JI, et al. HLA-DR antigens and rheumatoid arthritis in black South Africans: a study of ethnic groups. Tissue Antigens. 1992;39(3):138–40.
  • Lee DM, Phillips R, Hagan EM, et al. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis. 2009;68(2):201–8. doi:10.1136/ard.2007.084509.
  • Raza K, Falciani F, Curnow SJ, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 2005;7(4):R784–95.
  • Jacoby RK, Jayson MI, Cosh JA. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11 years follow-up. Br Med J. 1973;2(5858):96–100.
  • Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med. 2001;111(6):446–51.
  • Möttönen T, Hannonen P, Korpela M, et al. Delay to institution of therapy and induction of remission using single drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002;46(4):894–8.
  • Halabi H, Alarfaj A, Alawneh K, et al. Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and the Middle East. Int J Rheum Dis. 2015;18(3):268–75. doi:10.1111/1756-185X.12320.
  • Hodkinson B, Musenge E, Ally M, et al. Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis. Clin Rheumatol. 2012;31(4):613–19 doi:10.1007/s10067-011-1900-5.
  • Massardo L, Aguirre V, García ME, et al. Clinical expression of rheumatoid arthritis in Chilean patients. Semin Arthritis Rheum. 1995;25(3):203–13.10.1016/S0049-0172(95)80032-8
  • Quinn MA, Emery P. Are early arthritis clinics necessary? Beat Pract Res Clin Rheumatol. 2005;19(1):1–17.10.1016/j.berh.2004.08.001
  • Bird P, Griffiths H, Tymms K, et al. The SMILE study—safety of methotrexate in combination with leflunomide in rheumatoid arthritis. J Rheumatol. 2013;40(3):228–35. doi:10.3899/jrheum.120922.